Total Company Value: catalent.com (CTLT)

Catalent, Inc - graphic logo of issuer CTLT

Catalent, Inc. (CTLT) is optimizing internal resources by outsourcing its IT operations and component procurement to third-party contractors. This price chart reflects an Enterprise Value of , which is critical given the risks of disrupted logistics and US trade restrictions. Catalent, Inc. (CTLT) operates as a global CDMO leader, developing vaccines and obesity treatments, which secures exceptional customer loyalty and attracts the attention of antitrust authorities.

CTLT (catalent.com) Total Company Value history from 07/04/2022 to 10/28/2026
Original product of Catalent, Inc.

Enterprise Value, which sums market capitalization and net debt to determine the actual cost of a full business buyout, is used to find the balance between asset quality and price. In the case of Catalent, Inc. (CTLT), a leader in the development of innovative drug delivery systems, the market value dynamics adjusted for net debt reflect the real-time assessment of the company's technological potential as a critical link in global pharmaceuticals.